© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Scientists introduced Metacycline Hydrochloride during the mid-20th century, marking a significant move forward in antibiotic research. The discovery stemmed from the drive to address a growing problem with bacterial resistance and a desire to widen the range of tetracyclines available for physicians and veterinarians. Early researchers hunted for derivatives of existing tetracyclines that could outmaneuver tricky pathogens and overcome issues with absorption and excretion. In the 1960s, a breakthrough came—chemists synthesized metacycline as an improved tetracycline analogue. You see, progress in antibiotics often comes from trial, error, and bold moves, and the history of metacycline reflects that approach. It didn’t remain a laboratory curiosity; after reports showed a broader activity spectrum and better pharmacokinetics, pharmaceutical companies quickly began clinical studies and production. Generations have relied on tetracyclines for a wide range of infections, and metacycline fit that puzzle, especially in areas dealing with resistant respiratory and urinary tract infections.
Metacycline Hydrochloride belongs to the family of tetracycline antibiotics, with a reputation for punching above its weight in treating both human and veterinary infections. Its hydrochloride salt improves solubility, helping absorb it more easily in the digestive tract compared to older tetracyclines. This feature gives prescribers and patients a practical advantage: better drug absorption means doses work more effectively, which matters every time. In practice, doctors reach for Metacycline Hydrochloride to treat acne, bronchitis, gonorrhea, and even tick-borne illnesses. Veterinarians use it in livestock to manage similar bacterial threats, though there’s growing attention to wise use because of resistance concerns. The product labels typically emphasize storage away from moisture, a clear nod to this compound’s sensitivity to water that could degrade it before it ever finds its way to a patient or animal.
Metacycline Hydrochloride appears as a yellow, crystalline powder. Its odor is faint but characteristic, and anyone who has handled it in a pharmacy or laboratory knows its sharpness. The salt’s molecular formula is C22H21ClN2O8·HCl. It dissolves well in water, which makes preparation for injection or oral solutions straightforward, but its stability drops in alkaline conditions, which can lead to a loss of potency. Because the molecule breaks down in strong light and heat, suppliers box it in light-proof containers and recommend refrigeration. The melting point usually sits above 200°C, and the compound exhibits slight hygroscopic behavior. These attributes remind every handler to respect proper storage conditions—a lesson driven home the hard way by those who witnessed spoiled inventory and diminished patient outcomes.
Drug regulations around the world require manufacturers of Metacycline Hydrochloride to meet tight technical standards. Purity generally must exceed 98%, with limits on heavy metals and microbial contaminants spelled out on certificates of analysis. Labels must state the precise amount of active ingredient, batch numbers, and expiration dates. They also need to feature clear directions about safe handling—avoid breathing in dust, keep out of sunlight, and store below 25°C. Packaging always includes information on contraindications, warnings about use in pregnant women and children, and a list of potential adverse effects. The emphasis on transparency isn’t just government red tape; it comes from decades of hard-earned experience in public health, shaped by thousands of patients and clinicians who’ve weighed safety against necessity.
The process begins with fermentation, as strains of Streptomyces bacteria churn out precursor compounds. Chemical engineers then extract and purify the raw materials, often using advanced chromatography. From there, synthetic chemists carry out modifications—introducing substituents at exact spots on the tetracycline nucleus—to yield metacycline itself. The final step involves conversion to the hydrochloride salt, boosting stability and solubility. Quality control checks run throughout every stage, from checking for byproducts to ensuring the product’s color and particle size meet strict parameters. Workers involved in this sequence benefit from training, detailed manuals, and oversight, often drawing on their own mix of academic training and hands-on know-how.
Metacycline stands out among tetracyclines because it bears a methyl group at carbon 6, introduced by directed chemical substitution. Such structural changes matter deeply—they alter the drug’s interaction with bacterial ribosomes, giving it a distinct spectrum of action. Modifying metacycline further has become a focus for teams searching for compounds better suited to target resistant bacteria or those with tricky pharmacokinetics. Researchers have explored halogenation and amination at specific rings, hoping to block enzymes that degrade tetracyclines in resistant bacteria. Some teams have tried to make prodrugs for better oral delivery. This sort of hands-on innovation, often driven by practical lab work and a strain of informed trial-and-error, shapes the pipeline of next-generation antibiotics.
Over the years, Metacycline Hydrochloride has appeared under several names. Synonyms include 6-Methyleneoxytetracycline hydrochloride and 6-Methyl-oxytetracycline hydrochloride. Pharmacists and suppliers recognize it through trade names such as Metacycline, Rondomycin, or Lysocline, names shaped by marketing as well as scientific convention. Regulatory documents sometimes use the term "metacyclinum hydrochloridum" in Latin. These naming conventions serve more than semantic purposes; they give clarity across languages and regulatory systems, which is critical for anyone navigating the tangle of international pharmaceutical trade and regulation.
Health workers, pharmacists, and factory personnel all face guidelines to keep themselves and their communities safe while working with Metacycline Hydrochloride. Chronic exposure can lead to skin, eye, and respiratory irritation, so protective gear—gloves, goggles, and masks—remains standard. Containers must carry hazard labels warning about dustiness and spill risks. Environmental concerns play a role too, since antibiotic runoffs threaten water supplies and downstream ecosystems. Waste streams from production and hospitals pass through rigorous treatments to degrade residual antibiotics. Much of this regional and global policy work draws from years of monitoring side effects and outbreaks linked to improper antibiotic handling or disposal. The path to safer operation comes from the ground up: it is built on the records, stories, and hard-earned lessons of workers and the communities they serve.
Clinicians reach for Metacycline Hydrochloride to treat human infections like acne vulgaris, chronic bronchitis, urinary tract infections, and rickettsial diseases. In some areas, it remains important for tackling zoonotic infections passed from livestock to people. Veterinarians deploy it against respiratory and gastrointestinal infections in cattle, pigs, and poultry. Beyond its main task as an antimicrobial, researchers have explored its use in preventing malaria or as a tool in studying ribosomal function in bacteria. Awareness of rising antibiotic resistance, though, means prescribers weigh their choices carefully, limiting use in non-critical cases. Hospitals and veterinary practices now carry stewardship programs that push back against overprescription and uncontrolled use, aiming to preserve the power of tetracyclines for when nothing else works.
Many labs chase after the next breakthrough by tweaking the chemical structure of metacycline. They design analogues with hoped-for improvements in targeting, stability, and resistance profile. Research teams draw on better screening methods to evaluate hundreds of variants each year, many of which never leave the petri dish. In academic settings, researchers also use Metacycline Hydrochloride as a model compound, probing bacterial protein synthesis or testing mechanisms of resistance transfer. Pharma companies still look for analogues that can dodge newer forms of resistance emerging in dangerous bacteria like Acinetobacter or certain staphylococci. Collaboration between universities and industry means every new generation of scientists picks up the baton from those who went before, working to outsmart the relentless march of microbial adaptation.
Animal and cell studies have narrowed down the toxicological profile of Metacycline Hydrochloride. Chronic exposure can lead to kidney and liver effects, and it shows teratogenic potential, so physicians avoid prescribing it to pregnant women unless absolutely necessary. In growing children, a risk of tooth discoloration and effects on bone growth made regulators caution or ban its use in those groups. Overdose cases point to gastrointestinal upset, dizziness, and, in rare cases, acute renal damage. Investigators have run painstaking long-term studies, measuring blood concentrations, organ changes and reproductive outcomes, making sure both human and animal populations get the benefit of hard evidence. The decades of surveillance, case reports, and careful monitoring have forged the restrictive labeling and guidelines now printed on every bottle and data sheet.
As resistance patterns shift and new threats emerge, Metacycline Hydrochloride finds itself at a crossroads. On one hand, its robust activity profile still offers relief in countries where newer antibiotics come with high price tags or limited distribution. On the other, more microbes are learning to dodge its punch. Scientists are working overtime to dream up new derivatives and formulations—especially those that target stubborn biofilms or deliver metacycline to hard-to-reach spots in the body. Policy makers and practitioners look beyond just new chemicals: stewardship programs, rapid diagnostics, and public education campaigns all form part of the toolbox to keep what works, working. In my own experience, seeing treatment failures and long hospitalizations drives home the urgency—saving antibiotics like Metacycline Hydrochloride for truly necessary cases gives us a fighting chance to buy time for smarter solutions. The next few years will test how much life remains in this storied compound, but the lessons it has taught about stewardship, innovation, and vigilance will certainly shape what comes next.
Metacycline Hydrochloride shows up on the list of older tetracycline antibiotics trusted by plenty of doctors worldwide. Many healthcare workers remember it for its power to tackle all sorts of bacterial infections. Infections like acne, pneumonia, urinary tract infections, and even some stubborn sexually transmitted diseases bring out the need for this medicine. It works by holding back bacteria’s ability to make proteins, which puts the brakes on their growth. That makes it helpful when facing illnesses that do not respond to plain penicillin or newer options.
Most folks might associate antibiotics with common names like amoxicillin or doxycycline, but metacycline hydrochloride has carved its own place, especially in areas where resistance and cost matter. Doctors often have to make quick decisions in clinics that don’t have all the resources or where the price of newer drugs keeps them out of reach. Here, metacycline hydrochloride serves as a cost-effective option. In my time volunteering at a small community clinic, the shelves rarely carried all the latest medications, but we counted on this antibiotic for skin problems that just would not clear up, and it did the job plenty of times.
Antibiotic resistance has grown into a serious problem across the globe. The Centers for Disease Control and Prevention report that each year in the United States alone, millions end up infected with bacteria that resist common drugs. Metacycline hydrochloride, like its close tetracycline relatives, once acted as a fix for a wide swath of infections. Overuse and misuse have chipped away at that power in some places. Doctors rely on precise diagnoses and lab data to guide decisions, so that these medicines work when they are truly needed. Handing out antibiotics for every cough or sniffle only leads to trouble down the line. The answer comes with following guidelines and checking bacteria sensitivity whenever possible.
Taking antibiotics, including metacycline hydrochloride, often means dealing with unwanted effects. Nausea, diarrhea, and rashes show up in clinic visits more often than most people realize. Sensitivity to sunlight can leave a person with serious burns after spending only an hour outside. Children under age eight and pregnant women steer clear of drugs in the tetracycline group because they can cause tooth discoloration and problems with bone development. Every patient brings a unique set of risks, so a good provider will weigh benefits against dangers for each case. The World Health Organization and FDA encourage keeping antibiotics effective by staying alert to side effects and steering away from unnecessary prescriptions.
Doctors, pharmacists, and everyday people all share the responsibility to make sure antibiotics work for years to come. Taking every dose as prescribed, not sharing leftover pills, and avoiding pressure on doctors to give antibiotics for viral infections play a major role. Researchers keep searching for new treatment methods and improved guidelines. Simple education about antibiotic stewardship and honest talk about risks go a long way. Patients who ask questions and get solid answers from healthcare workers end up making informed choices, which adds up to healthier communities over time.
Choosing an antibiotic always comes with real questions about dose and safety. Metacycline Hydrochloride, a member of the tetracycline family, gets prescribed for stubborn infections -- things like acne, urinary tract infections, some respiratory tract problems, and even tick-borne illnesses. Many people just want to know how much to take and how often, but it’s easy to miss how much that actually depends on your exact situation. Too much invites gut trouble, yeast overgrowth, or worse; too little and the bacteria don’t get beaten back. I’ve seen friends finish an antibiotic too soon and the problem comes roaring back, or go off-label with dosing and end up battling side effects for weeks.
Adults usually get prescribed 250 to 500 milligrams every six hours — that's four times a day. The amount can change depending on what needs treating. Someone with a mild skin infection might land on the low end, while a deep-seated lung bug could mean sticking with the higher side, pushing to the full 500 milligrams per dose. In kids, doctors cut everything down to weight-based dosing, usually about 25 to 50 milligrams per kilogram of body weight each day, divided into equally spaced doses.
What sometimes gets overlooked is how food can get in the way. Metacycline, like its tetracycline cousins, absorbs best on an empty stomach. Dairy, antacids, and even some supplements can take a bite out of its power, tying up the medicine so your gut never lets it in. I remember my neighbor fighting persistent sinus infections, always taking her antibiotic with a huge glass of milk. The infection dragged on far too long.
Doctors keep a close eye on how long to continue therapy. For a typical run-of-the-mill infection, about 7 to 14 days covers it. But stubborn cases, like acne, sometimes stretch out for months — always under a doctor’s eye. There’s a tightrope act here: stop too soon and the infection rides out the weak assault, keep going too long and your gut bacteria get wiped out, or you breed resistant bugs. The CDC pegs antibiotic resistance as one of the biggest threats facing healthcare today — at least 2.8 million Americans get sick with a drug-resistant infection each year.
Sunburn comes fast on these meds. Anyone taking metacycline needs to know sunlight turns mild exposure into a lobster-red disaster. Sensitive teeth and a tender stomach show up a lot too, especially for people who don’t respect that empty-stomach rule. Younger kids, especially under age eight, might face stained teeth forever — which makes this family of antibiotics an absolute no-go for them unless it’s a last resort.
Metacycline Hydrochloride has proven itself for decades, yet smart use demands more than just reading a label. Skipping doses or guessing the amount brings more harm than help. Open communication with a doctor matters more than most folks realize; nobody’s health wins with a leftover prescription shuffled in from a friend or family member. Cleveland Clinic and Mayo Clinic both recommend finishing the full course, sticking to the schedule, and reporting any weird symptoms right away. Good stewardship reflects in every pill taken—fewer superbugs, healthier guts, and infections that finally clear.
Metacycline hydrochloride belongs to a group of medicines called tetracycline antibiotics. Doctors often prescribe it to treat bacterial infections like bronchitis, urinary tract issues, and even some skin problems. Antibiotics usually do their job well, but like any medicine, this one has its rough edges.
Stomach troubles tend to come up for people using metacycline hydrochloride. Nausea or an upset belly can show up soon after starting the pills. Kids and adults both can get hit with diarrhea or lose their appetite. Sometimes people get a metallic taste in their mouth that lingers way too long. These symptoms can be tough, especially if someone already doesn’t have much energy from fighting an illness. Based on some conversations with friends who have tried this drug, reaching for a simple meal or crackers—but nothing too spicy or greasy—can bring a bit of comfort.
Skin rashes tell another part of the story. Sunburns can get worse or happen faster—these medicines make the skin extra sensitive to sunlight, even on cloudy days. I always wear sunscreen and long sleeves when using medicines like this, and I suggest others do the same. Sometimes the rash looks like itchy patches, raised bumps, or red spots. These rashes might fade on their own, but severe ones should prompt a call to a healthcare professional.
It’s rare, but allergy-type reactions can develop. Hives, swelling in the face, and trouble breathing qualify as medical emergencies. These kinds of problems don’t crop up often, but ignoring them can turn risky very quickly.
Teeth discoloration is a real worry for children and pregnant women. Medicines in this class settle into growing teeth and bones, turning them yellow or gray. The FDA and CDC both say to steer clear of tetracyclines for this reason in kids under 8 years old or during pregnancy. This knowledge can help families make smarter choices and avoid long-term regrets.
Liver issues sometimes sneak up on people with long-term use or higher doses. Some might notice dark urine, severe fatigue, or pain in the upper stomach. These symptoms usually come with warning signs, but ignoring them only leads to bigger hurdles down the line.
Those who already struggle with liver or kidney problems carry extra risk. They can’t clear medicines like metacycline hydrochloride from their system as quickly, raising the risk of more severe side effects. Mixing this medicine with antacids, dairy, or iron supplements can lower how much the body absorbs, making it less effective. It’s worth reminding folks always to double-check what foods or meds might mess with their prescription.
Don’t wait around if anything feels off. Rashes, difficulty swallowing, or persistent stomach upset mean it’s time to call the doctor. Small steps like taking the medication with a full glass of water and avoiding lying down right after help protect the throat and stomach. I’m always quick to jot down changes and bring them to the next medical appointment—nothing beats a detailed list when discussing symptoms or planning treatment changes.
Above all, metacycline hydrochloride requires caution, respect for possible side effects, and clear communication with health providers. Anyone feeling uncertain should speak up and ask questions. This approach protects health not just in the short run, but for the long haul.
Doctors have often relied on Metacycline Hydrochloride to manage tough bacterial infections. This antibiotic, related to the tetracycline family, brings real utility for difficult microbes. Still, it’s important for everyone involved—doctors, pharmacists, and patients—to know its risks, especially the ways it may tangle with other medicines or create avoidable complications.
Pregnant women and young children face particular danger with this drug. Metacycline, like other tetracyclines, can stain the developing teeth of children or unborn babies. Pregnant women risk tooth discoloration in their unborn child, and children younger than eight can experience permanent tooth problems and slow bone growth. People with a known allergy to tetracyclines should definitely steer clear, as serious allergic reactions may show up fast.
A doctor will think twice about prescribing this drug to anyone with severe liver or kidney issues. The body relies heavily on these organs to filter out toxins and byproducts, and damaged systems struggle with that load. Accumulating the drug in the bloodstream can magnify side effects or spark new ones, including skin reactions and extreme sensitivity to sunlight.
Metacycline Hydrochloride doesn’t work in a vacuum. Taking antacids that contain aluminum, calcium, or magnesium, or even iron supplements, can block the body from using the antibiotic properly. These minerals bind up the antibiotic, making it far less effective. To keep this from happening, doctors usually tell people to stagger these doses by at least two hours.
Birth control pills deserve special attention. Tetracyclines have a reputation for sometimes weakening contraceptive protections, which absolutely matters in the real world. Studies show the risk is likely small, but it happens enough to warrant backup precautions. I’ve seen this surprise crop up in pharmacy counseling more than once.
Blood thinners like warfarin come with their own headache. Metacycline increases the blood-thinning effect, which can tip a patient into dangerous territory with bleeding. Only careful blood monitoring keeps things safe, something every experience-driven pharmacist will confirm after a close call or two.
The combination of Metacycline Hydrochloride and certain epilepsy drugs, such as phenytoin or carbamazepine, speeds up the breakdown of the antibiotic, leaving subpar amounts in the system. This may let bacteria survive and resist future treatment. Doctors and pharmacists catch these mistakes by reviewing every medication list, but it always pays for patients to keep their list up to date.
Patients using methoxyflurane, a rare anesthetic, face life-threatening kidney toxicity if they also get Metacycline. Even though most people rarely run into methoxyflurane these days, it demonstrates how old-school drugs can still pose deadly threats in select situations.
Knowing about these pitfalls helps everyone—from busy ER doctors to families managing at-home prescriptions. The goal is not just to fix today's infection but to ensure tomorrow doesn't hold new dangers. Patients should speak up about all medicines and supplements, even the herbal ones. Pharmacists continue to play a big role as a last line of defense. Education and honest conversation between patients and healthcare professionals guide safer choices, steer clear of needless risk, and take advantage of the best medicines science offers.
Metacycline Hydrochloride works as an antibiotic and belongs to the tetracycline family. In clinics and hospitals, it takes on everything from skin infections to respiratory illnesses. Drugs in this category have a proven history. Most doctors learned early in training to watch closely who receives these medications, especially among women expecting a child or caring for a newborn. The reasons matter, and most folks looking for an answer want clarity, not just textbook language.
Prenatal care routines always focus on reducing potential harm, and that includes drug safety. Metacycline, like other tetracyclines, crosses the placenta. The problem doesn’t just show up in long-term health studies; it becomes clear in babies born with discolored teeth and sometimes problems with bone development. This risk comes from scientific evidence, not just hospital anecdotes. Multiple studies show that the effects can appear even if the mother only takes the drug for a few days. Researchers haven’t stopped there. Reports suggest a higher risk of liver problems in pregnant women using this medicine compared to other antibiotics. A quick conversation with any OB-GYN will usually confirm this risk profile.
Breastmilk acts as a lifeline for newborn nutrition, so parents want to know exactly what comes through. Metacycline passes into breastmilk in measurable amounts. Teeth discoloration isn’t the only concern. There’s also a possibility of bone growth interruption for babies who receive even trace amounts over time. The American Academy of Pediatrics and The World Health Organization both list tetracyclines as potentially harmful for nursing infants. Not every baby will show side effects, but the stakes run high enough that most doctors head off these risks entirely by choosing safer alternatives. Even taking a break from breastfeeding so you can use this drug for an infection can mess with feeding routines and milk supply, adding more stress to an already hectic period.
No one likes facing an infection while pregnant or breastfeeding. The truth is, most common infections have multiple treatment routes. Modern guidelines recommend penicillins, cephalosporins, or macrolides for many illnesses because they don’t carry the same risks as tetracyclines. Pharmacists work alongside doctors every day to make sure prescriptions won’t leave babies or mothers vulnerable. If you spot Metacycline on your prescription while expecting or breastfeeding, a direct talk with your healthcare team works better than searching alone online. Health professionals need to know all medications you take, including over-the-counter products and supplements. This teamwork helps protect both parent and baby.
Personal stories fill hospital waiting rooms. One family’s experience losing trust in a medication advice changed the way our clinic handles prescribing for pregnant and nursing moms. Mistakes do happen, but the goal remains to prevent them through transparency and careful listening. Asking doctors about risks, reading prescription labels, and reporting side effects gives parents back some control. Expecting strict rules and detailed explanations from your care team is justified; too much hangs in the balance. Health information found through reliable sources like Mayo Clinic and CDC also helps reinforce safe habits. Drug safety isn't just a technical detail—it’s about families making it through tough times as smoothly as possible.
| Names | |
| Preferred IUPAC name | (4S,4aS,5aR,6S,12aS)-4-(Dimethylamino)-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride |
| Other names |
Physiomycine Metacycline Metatilan Metacyclinum hydrochloridum |
| Pronunciation | /ˌmɛtəˈsaɪklɪn haɪˌdrɒkləˈraɪd/ |
| Identifiers | |
| CAS Number | 7417-39-6 |
| Beilstein Reference | 3191983 |
| ChEBI | CHEBI:75267 |
| ChEMBL | CHEMBL2107617 |
| ChemSpider | 8140072 |
| DrugBank | DB00760 |
| ECHA InfoCard | CHEMICAL: 100.121.410 |
| EC Number | 25938-97-0 |
| Gmelin Reference | 79553 |
| KEGG | D08130 |
| MeSH | D008774 |
| PubChem CID | 71813 |
| RTECS number | QJ0525000 |
| UNII | 317PH844G1 |
| UN number | UN2811 |
| Properties | |
| Chemical formula | C22H22N2O8·HCl |
| Molar mass | 510.94 g/mol |
| Appearance | Light yellow crystalline powder |
| Odor | Odorless |
| Density | 1.5 g/cm3 |
| Solubility in water | Freely soluble in water |
| log P | -0.55 |
| Acidity (pKa) | 0.9 |
| Basicity (pKb) | -4.46 |
| Magnetic susceptibility (χ) | -93.0e-6 cm³/mol |
| Refractive index (nD) | 1.695 |
| Dipole moment | 5.67 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 438.1 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | J01AA10 |
| Hazards | |
| Main hazards | Harmful if swallowed. Causes serious eye irritation. May cause respiratory irritation. |
| GHS labelling | GHS05, GHS07, Danger, H315, H319, H335 |
| Pictograms | GHS05,GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. H319: Causes serious eye irritation. H335: May cause respiratory irritation. |
| Precautionary statements | P264, P270, P273, P280, P301+P312, P305+P351+P338, P308+P313, P330, P501 |
| Flash point | > 287.2°C |
| Autoignition temperature | 600 °C |
| Lethal dose or concentration | LD50 oral rat 1700 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Metacycline Hydrochloride is "2214 mg/kg (oral, mouse)". |
| NIOSH | QN6475000 |
| PEL (Permissible) | PEL (Permissible Exposure Limit) for Metacycline Hydrochloride: "PEL not established |
| REL (Recommended) | 200 mg daily |
| Related compounds | |
| Related compounds |
Demethylchlortetracycline Tetracycline Chlortetracycline Oxytetracycline |
